Product Information

ETODOLAC ER 400 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.5912 per EA under NDC 68382027114. Its NADAC has been published 645 times since Jul 9, 2014.

FDA first approved this application on Jan 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ETODOLAC ER 400 MG TABLET

Etodolac
$0.5912per EA

Strength

400 mg/1

NDC

68382027114

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ETODOLAC

Approval Type

Generic (ANDA)

FDA Application

ANDA091134

FDA Approved

1/23/2014

TE Code

AB

On Market Since

2/15/2014

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for ETODOLAC ER 400 MG TABLET has been published 645 times since Jul 9, 2014, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5912 per EA
All-time high$2.2890 (Jun 15, 2016)
All-time low$0.5912 (Oct 21, 2026)
52-week high$1.1052
52-week low$0.5912
Median price$1.8356
Average price$1.6346
Largest weekly change+52.0% (Jun 21, 2023)
Weeks tracked645
Tracking sinceJul 9, 2014

Price History

1W

0.0%

1M

-4.0%

3M

-33.3%

6M

-44.7%

1Y

-40.5%

3Y

-51.4%

5Y

-69.7%

All

-72.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ETODOLAC ER 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC ER 400 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.5912 per EA (NDC 68382027114), effective Nov 11, 2026.

How has the price of ETODOLAC ER 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for ETODOLAC ER 400 MG TABLET has declined 72.9%. It has been tracked across 645 weekly CMS publications since Jul 9, 2014.

What are the highest and lowest recorded NADAC prices for ETODOLAC ER 400 MG TABLET?

Since Jul 9, 2014, the NADAC for ETODOLAC ER 400 MG TABLET has ranged from a low of $0.5912 (Oct 21, 2026) to a high of $2.2890 (Jun 15, 2016), with a median of $1.8356 per EA.

Are there cheaper alternatives to ETODOLAC ER 400 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETODOLAC 400 MG TABLET, is $0.2710 per EA — about 54% below ETODOLAC ER 400 MG TABLET.

Who manufactures ETODOLAC ER 400 MG TABLET?

ETODOLAC ER 400 MG TABLET (NDC 68382027114) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.